Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Atea Pharmaceuticals Inc (AVIR)

Atea Pharmaceuticals Inc (AVIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 324,259
  • Shares Outstanding, K 84,223
  • Annual Sales, $ 0 K
  • Annual Income, $ -135,960 K
  • 60-Month Beta 0.17
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.67
Trade AVIR with:

Options Overview Details

View History
  • Implied Volatility 0.00% ( -146.18%)
  • Historical Volatility 52.62%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 410.05% on 10/20/23
  • IV Low 0.00% on 08/30/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 38
  • Put/Call OI Ratio 7.02
  • Today's Open Interest 8,042
  • Open Int (30-Day) 8,139

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.59
  • Number of Estimates 2
  • High Estimate -0.45
  • Low Estimate -0.72
  • Prior Year -0.40
  • Growth Rate Est. (year over year) -47.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.20 +20.31%
on 08/06/24
3.99 -3.51%
on 08/26/24
+0.03 (+0.79%)
since 07/30/24
3-Month
3.14 +22.42%
on 07/10/24
4.01 -3.87%
on 06/05/24
+0.24 (+6.65%)
since 05/30/24
52-Week
2.77 +39.24%
on 11/22/23
4.60 -16.30%
on 02/29/24
+0.49 (+14.58%)
since 08/29/23

Most Recent Stories

More News
Markets Today: Stocks Mixed After Hawkish ECB Comments

Morning Markets December S&P 500 futures (ESZ22 ) this morning are down by -0.52%. U.S. stock indexes today are under pressure on concern that interest rate hikes by the world’s central banks to combat...

ESU24 : 5,661.00s (+0.91%)
DVN : 44.78 (-0.49%)
FANG : 195.11 (-0.85%)
XOM : 117.94 (-0.16%)
COP : 113.79 (-0.51%)
HAL : 31.09 (-0.92%)
OXY : 56.98 (-0.40%)
MRO : 28.65 (-0.69%)
DSX : 2.50 (+2.46%)
SB : 5.11 (+1.39%)
FTCH : 0.6428 (-13.26%)
FCX : 44.28 (+1.03%)
Atea Pharmaceuticals, Inc. (AVIR) Q2 2022 Earnings Call Transcript

AVIR earnings call for the period ending June 30, 2022.

AVIR : 3.85 (+1.85%)
Atea Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

Advancing Bemnifosbuvir to Late-Stage Development for COVID-19 Following Meetings with U.S. Food and Drug Administration (FDA) and European Medicines...

AVIR : 3.85 (+1.85%)
Atea Pharmaceuticals to Host Second Quarter 2022 Financial Results Conference Call on August 8, 2022

BOSTON, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today announced...

AVIR : 3.85 (+1.85%)
Atea Pharmaceuticals Participates in the William Blair Biotech Focus Conference

BOSTON, July 11, 2022 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today announced...

AVIR : 3.85 (+1.85%)
Use This 1 Genius Trick for Finding Dirt Cheap Biotech Stocks in the Bear Market

This metric will show you which companies are being valued at potentially unreasonably low levels.

XBI : 101.26 (+0.35%)
AVIR : 3.85 (+1.85%)
Atea Pharmaceuticals to Present at the 2022 Jefferies Healthcare Conference

BOSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today announced...

AVIR : 3.85 (+1.85%)
Atea Pharmaceuticals, Inc. (AVIR) Q1 2022 Earnings Call Transcript

AVIR earnings call for the period ending March 31, 2022.

AVIR : 3.85 (+1.85%)
Atea Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update

New clinical results from MORNINGSKY trial shows 71% reduction in hospitalization (secondary endpoint) in broad patient population with COVID-19 treated...

AVIR : 3.85 (+1.85%)
Atea Pharmaceuticals Reports Nonclinical Bemnifosbuvir (AT-527) Toxicology Data at Society of Toxicology 61st Annual Meeting

Bemnifosbuvir Demonstrated Favorable Overall Nonclinical Safety Profile, Including Lack of Reproductive and Development Toxicity in Animal Models...

AVIR : 3.85 (+1.85%)

Business Summary

Atea Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing antiviral therapeutics to improve the lives of patients suffering from life-threatening viral infections. Atea Pharmaceuticals Inc. is based in BOSTON.

See More

Key Turning Points

3rd Resistance Point 4.09
2nd Resistance Point 3.98
1st Resistance Point 3.91
Last Price 3.85
1st Support Level 3.73
2nd Support Level 3.62
3rd Support Level 3.55

See More

52-Week High 4.60
Fibonacci 61.8% 3.90
Last Price 3.85
Fibonacci 50% 3.68
Fibonacci 38.2% 3.47
52-Week Low 2.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar